The National Comprehensive Cancer Network (NCCN), an organization of 19 of the world's leading cancer centers, developed and communicated a cancer pain treatment guideline. NCCN seeks to implement guidelines through performance measurement using a NCCN Oncology Outcomes Database. This is a preliminary report from the NCCN Cancer Pain Management Database Project. The primary objective of this NCCN Cancer Pain Management Database Project study is to evaluate the frequency, methods, and extent of documentation of cancer pain assessment and management at NCCN institutions. A pain data dictionary and related data collection forms were first developed. The records of 209 breast cancer patients with bone metastases were then studied. The frequency of pain mentions, type of pain assessment tool used, pain characteristics, type of clinician documenting pain, location in the medical record, and pain treatment characteristics were noted. The majority of clinical encounters included pain mentions, although considerable vari-
ability was found in pain documentation between providers and between inpatient and outpatient settings. Nurses more frequently recorded pain, usually as a numeric pain intensity score. Pain specialists were more likely to record a complete description of pain. A significant minority of patients experienced moderate to severe pain. In a small subgroup of patients with moderate to severe pain, pain treatment was not recorded. The undertreatment of cancer pain has been a focus of investigation and review for the past two decades. Quality improvement efforts to raise the standard of pain management have been underway. The results of this study highlight the need for standardization of pain documentation in comprehensive cancer centers as a prerequisite for the proper assessment of cancer pain and the improvement of clinical outcomes of pain management. (JNCCN 2004; 2; 173-180) The under-treatment of cancer pain has been a focus of investigation and review for the past 20 years.
1,2 Quality improvement efforts to raise the standard of pain management have been underway in many forms through diverse organizations. Renewed attention to this issue occurred in March of 1999, when the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) incorporated a set of comprehensive standards for the assessment and management of pain. JCAHO accredited hospitals and other health care facilities were required to comply with these standards by January 2001. Further recognition of the importance of pain management came from many organizations including the United States Department of Veterans' Affairs hospitals when they adopted pain as a uniform "fifth vital sign," mandating regular recording of pain intensity during clinical encounters.
In 2000, The National Comprehensive Cancer Network (NCCN), an organization of 19 of the world's leading cancer centers, developed and communicated a cancer pain treatment guideline. This supportive care guideline is an important component of the NCCN's Complete Library of Clinical Practice Guidelines in Oncology. 3 These guidelines are widely recognized and used as the standard for clinical cancer care.
The history of guideline development in American medicine is replete with examples of guidelines that have not as yet been fully applied in general practice. Barriers to and strategies for implementation of clinical practice guidelines have been identified. The NCCN guideline program has sought to address the issue of guidelines implementation in a number of ways. NCCN Clinical Practice Guidelines are delivered in a timely manner, are specific in their recommendations, and are updated at least annually. Furthermore, the NCCN seeks to implement guidelines through performance measurement in a NCCN Oncology Outcomes Database. By analyzing the Database, the NCCN measures the degree of concordance of practice in NCCN member institutions with specific NCCN guidelines, and the clinical outcomes associated with such practice patterns. The NCCN initially established specific databases in one solid tumor (breast cancer) and one hematologic malignancy (non-Hodgkin's lymphoma). The most recent database to be established is in supportive care (cancer pain). This is the first report from the NCCN Cancer Pain Management Database Project.
In 2001, investigators from five NCCN institutions initiated a study of documentation of pain assessment, pain management, and clinical outcomes of pain management. The primary purposes of the study were to determine the feasibility of using available clinical data to measure the concordance of cancer pain management practice with the NCCN Cancer Pain Clinical Practice Guidelines in Oncology and to evaluate clinical outcomes, such as alleviation of pain, achieved by such practice. In keeping with the goal of NCCN to raise the standard of comprehensive cancer care, we also anticipated that the study results would be used to formulate recommendations to member institutions regarding standardizing pain documentation. Improving the quality of pain management by uniform measurement of practice patterns and clinical outcomes would depend on standard pain documentation. Notably, no widely accepted uniform measures of clinical outcomes of pain management currently exist. In clinical practice, reduction of pain intensity, pain relief, side effects of treatment, adverse events, functional improvement, and quality of life are the relevant outcomes measures generally followed, and these are among the items recorded in this study (Weinstein, 
Study Objectives
The primary objective of this NCCN Cancer Pain Management Database Project study is to evaluate the frequency, methods, and extent of documentation of cancer pain assessment and management at NCCN institutions. We were interested in documentation of patient and disease characteristics, as well as of clinical interventions and the outcomes associated with such treatment.
Comprehensive pain evaluation includes eliciting patient self-report, taking complete history, performing physical examination, and reviewing clinical information to determine the "pain diagnosis," or the pathophysiology of the pain complaint. The assessment of pain is the necessary first step in clinical pain management. In this study, "pain mentions" are defined as discrete documentations of pain in the medical record. Pain mentions include verbal mentions in narrative material, numeric intensity ratings found in various locations in the record, and explicit narrative entries denoting the absence of pain. Narrative phrases such as "no abdominal pain/discomfort" or "no chest pain" in the physical examination or review of systems sections of a clinical note were not considered pain mentions for the purposes of this study. Only pain documented as patient self-report was abstracted from the record as a pain mention. The frequency of pain mentions, type of pain assessment tool used, pain characteristics, type of clinician documenting pain, and the location in the medical record were noted. Pain characteristics include body location, pain intensity rating, pain quality descriptors, pathophysiologic type of pain, and pain etiology. Pain treatment characteristics include the treating team (primary team or pain specialist), the analgesic treatment methods used, and adverse events associated with analgesic treatment.
Study Design
The initial step was to create a comprehensive pain data dictionary including demographic, cancer-re-lated, and pain-related information. A panel of experts in pain management and research was convened to identify relevant data elements for inclusion in the data dictionary, which was then used to create data collection forms. We conducted a preliminary review of the extent of pain documentation in cancer patients' medical records to determine feasibility of the study. The current study consists of a retrospective review of medical records.
A cohort of consecutive cases seen for oncologic care at the five participating NCCN institutions between Trained clinical research associates (CRAs) used standardized data collection forms during chart abstraction. Data quality was ensured by two methods. First, bimonthly electronic data queries were run, with suspicious data entries flagged and sent to the CRAs for review and correction. Additionally, 10% of the patients' records were audited on-site against source documentation for major and minor violations before data analysis.
Data and Data Sources
Data were collected from the retrospective review of serially eligible patients' outpatient and inpatient medical records from the baseline clinic visit through 3 months after the initial visit. Data collected included pain mentions, type of pain assessment tool, type of clinical personnel recording pain, location of pain mention in the medical record, pain characteristics, pain treatment characteristics, and clinical outcomes. Sociodemographic data, comorbidity at the baseline clinic visit, breast cancer characteristics, and antineoplastic therapy administered (surgery, radiation, or systemic therapy) are recorded also. Comorbidity at the baseline clinic visit to the NCCN center was assigned using the Charlson Comorbidity score. 4 
Statistical Analyses
The cohort consisted of records of 209 individual patients with a total of 3,348 pain mentions. Descriptive analyses of the patterns of pain documentation are presented in Figures 1 through 10 . Standard errors were calculated for binomial proportions. Table 1 shows demographic and clinical characteristics of the 209 patients at the time of study entry. The median age at the time of analysis was 54 years (range, 29-86 years). These breast cancer patients exhibited a median time to relapse or first presentation with bony disease of almost 3 years (median, 2.9 years; range, -25.3 years) and a time from diagnosis with metastatic disease to study entry of 1.5 years (range -11.2). Seventy-eight percent of patients had multiple organ involvement. The extent of skeletal metastatic disease (number of lesions) is what one would expect in this population, with most patients having more than one site of bony tumor involvement (25% with 1-3 lesions and 69% with 4 or more lesions). Many patients had undergone several different chemotherapeutic regimens, and 92% (193 of 209) of patients had received bisphosphonate therapy. Fifty-four percent (113 of 209) of the subject population had undergone radiation treatment prior to study entry.
Results
Patients in general had comorbidity scores of zero (73%) or one to two (22%). Interestingly, many (56%) patients had no recorded opioid use before enrollment in the study. Approximately 20% of patients with documented opioid use had a history of adverse events; those were usually typical drug-related side effects common to opioid analgesics.
Ninety-nine percent of patients (207 of 209) had at least one pain mention documented in the outpatient setting during the 3-month study period (Fig. 1) . Eighty-one percent (32 of 41) of patients with an inpatient stay or emergency room visit had a documented pain mention during hospitalization. Figure 2 shows that 125 of 209 patients (60%) had a pain mention in at least 75% of their outpatient visits. Overall, 84% of records had a pain mention in at least half of the outpatient visits. Figure 3 shows that pain mentions were more likely to be numeric than verbal in the outpatient setting (55% numeric and 45% verbal), and more likely to be verbal mentions in the inpatient setting (65% numeric and 35% verbal). Most pain mentions in the sample were recorded by nurses and nurse assistants (81% inpa- tient pain mentions and 65% outpatient pain metions) during nursing assessment (Fig. 4) . Figure 5 shows the extent to which the specific pain characteristics of body location, etiology, and pathophysiology were recorded concurrent with a pain mention. Although the location of pain was noted in more than 60% of all pain mentions, characterizations of etiology and pathophysiology occurred much less often (<20% for each). Among encounters with pain mentions, the 3 important characteristics of location, etiology, and pathophysiology were not recorded consistently across provider types. The proportions for nurses, oncologists, and pain team physicians for recording all 3 characteristics were 7%, 26%, and 45%, respectively (Fig. 6) .
We are reporting on a total of 3,348 numeric and verbal pain mentions. Figures 7 and 8 show the distribution of numeric pain intensity scores and the highest pain intensity scores recorded for patients with numeric pain mentions. Numeric pain intensity scores were zero in over half of the numeric pain mentions. Moderate (4 to 6) and severe pain (7 to 10) scores accounted for between 9% and 20% of all recorded numeric pain mentions in the inpatient and outpatient settings (Fig. 7) . Of the patients with at least one recorded numeric rating, 55% (n = 69) had moderate to severe pain as the highest score recorded (Fig. 8) . For this cohort of 69 patients, 14 patients had no recorded intervention for the management of pain, 11 patients had only the use of a nonopioid analgesic recorded as the therapeutic intervention, and 44 patients were documented to have received a strong opioid. Figures 9 and 10 show the types of treatment and types of opioids prescribed as recorded in both the inpatient and outpatient settings.
Discussion
The present study is a preliminary analysis of the type and extent of documentation of pain in a cohort of patients with metastatic breast cancer expected to have a high prevalence of pain. This study focused on pain over a 3-month interval in both the outpatient and inpatient settings. Overall, the documentation of pain was extensive. Almost all records had a least one documented pain mention in the outpatient setting, and pain. 6 Before proper pain management outcomes evaluations can be performed, formal, systematic documentation of pain, its treatment, the outcomes of such treatment, and ongoing care must be uniformly established. Such explicit documentation is necessary because studies have shown that subjective estimation of practice patterns by individual physicians and other health care professionals can both underestimate and overestimate pain and analgesic interventions. 7 Although documentation of pain is extensive in the 5 participating institutions, the documentation itself is not consistent within institutions or across centers. We found considerable variability of pain documentation across provider types. Documentation of pain intensity by numeric rating, the preferred evaluative method, occurred in only half of the pain mentions. Also, pain location, etiology, and pathophysiology were not recorded in the majority of cases. Such information is critical to choosing analgesic interventions. Nurses were responsible for the majority of pain mentions in the record and were most likely to record numeric pain intensity ratings alone. Pain specialists and specialty teams were most consistent and thorough in documenting pain in a comprehensive manner as expected.
Fifty-five percent of patients with a numeric pain mention experienced moderate to severe pain at least one time during the 3-month interval. Twenty-five patients in this patient subgroup had either no recorded intervention or a nonopioid analgesic as the most potent clinical intervention. These findings suggest that for this group, there was incomplete documentation of analgesic interventions or pain was, infact, untreated. the majority of records had a pain mention in at least 75% of outpatient visits. It is not known how much pain documentation has improved since the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) mandated compliance with pain assessment at every clinical encounter.
Lack of clinician education, misunderstanding of opioid prescribing, patients' reluctance to use opioids, and prescribers' fears of regulatory agency scrutiny are among the many reasons that have been cited to account for the continuing undertreatment of cancer Preliminary analysis of these 209 patient records suggests opportunities for improvement in the documentation of cancer-related pain and its management. Documentation of pain intensity should occur through the application of a standardized numeric pain intensity rating scale. The location, etiology, and pathophysiology of pain should be determined and clearly documented. Documentation of treatment should include complete recording of analgesic interventions and clinical outcomes. In toto, pain documentation should be consistent and complete in both the outpatient and inpatient settings and across institutions if we are to be able to fully evaluate cancer pain treatment outcomes.
Identification of deficiencies in and opportunities to improve pain treatment in the cancer patient depend on improved standardization, reporting and analysis of pain assessment, analgesic interventions, and clinical outcomes information. Such data would allow clinical professionals and institutions to evaluate the extent to which their practices are consistent with established guidelines to manage cancer pain. The present study shows that opportunities for improvement in the recording, collection and analysis of clinical data do exist. The present analysis also indicates the need for more extensive and complete documentation in pain
